 | • レポートコード：MRC2-11QY12230 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医療関連感染（HAI）診断のグローバル市場について調査・分析したレポートです。種類別（分子診断検査、その他体外診断検査）市場規模、用途別（菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療関連感染（HAI）診断の競争状況、市場シェア ・世界の医療関連感染（HAI）診断市場：種類別市場規模 2015年-2020年（分子診断検査、その他体外診断検査） ・世界の医療関連感染（HAI）診断市場：種類別市場規模予測 2021年-2026年（分子診断検査、その他体外診断検査） ・世界の医療関連感染（HAI）診断市場：用途別市場規模 2015年-2020年（菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、その他） ・世界の医療関連感染（HAI）診断市場：用途別市場規模予測 2021年-2026年（菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、その他） ・北米の医療関連感染（HAI）診断市場分析：米国、カナダ ・ヨーロッパの医療関連感染（HAI）診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療関連感染（HAI）診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療関連感染（HAI）診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療関連感染（HAI）診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BioMérieux、Abbott Laboratories、Roche AG、Siemens Healthcare ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.
The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.
Market Analysis and Insights: Global Hospital Acquired Infections (HAI) Diagnostics Market
The global Hospital Acquired Infections (HAI) Diagnostics market size is projected to reach US$ 3485.1 million by 2026, from US$ 3331.9 million in 2020, at a CAGR of 4.3%% during 2021-2026.
Global Hospital Acquired Infections (HAI) Diagnostics Scope and Market Size
Hospital Acquired Infections (HAI) Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections (HAI) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
BioMérieux
Abbott Laboratories
Roche AG
Siemens Healthcare
…
Market segment by Type, the product can be split into
Molecular Diagnostics Tests
Other In-vitro Diagnostic Tests
Market segment by Application, split into
Bloodstream Infections (BSI)
Urinary Tract Infections (UTI)
Surgical Site Infections (SSI)
Pneumonia
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Acquired Infections (HAI) Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Molecular Diagnostics Tests
1.4.3 Other In-vitro Diagnostic Tests
1.5 Market by Application
1.5.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Bloodstream Infections (BSI)
1.5.3 Urinary Tract Infections (UTI)
1.5.4 Surgical Site Infections (SSI)
1.5.5 Pneumonia
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Perspective (2015-2026)
2.2 Global Hospital Acquired Infections (HAI) Diagnostics Growth Trends by Regions
2.2.1 Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Acquired Infections (HAI) Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Acquired Infections (HAI) Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Acquired Infections (HAI) Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Market Size
3.1.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio
3.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2019
3.3 Hospital Acquired Infections (HAI) Diagnostics Key Players Head office and Area Served
3.4 Key Players Hospital Acquired Infections (HAI) Diagnostics Product Solution and Service
3.5 Date of Enter into Hospital Acquired Infections (HAI) Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
5.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
6.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in North America (2019-2020)
6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
6.4 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
7.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
7.4 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
8.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in China (2019-2020)
8.3 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
8.4 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
9.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
9.4 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
10.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
11.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in India (2019-2020)
11.3 India Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
11.4 India Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2020)
12.2 Hospital Acquired Infections (HAI) Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 BioMérieux
13.1.1 BioMérieux Company Details
13.1.2 BioMérieux Business Overview
13.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Introduction
13.1.4 BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020))
13.1.5 BioMérieux Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Introduction
13.2.4 Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Roche AG
13.3.1 Roche AG Company Details
13.3.2 Roche AG Business Overview
13.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Introduction
13.3.4 Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020)
13.3.5 Roche AG Recent Development
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Details
13.4.2 Siemens Healthcare Business Overview
13.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Introduction
13.4.4 Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020)
13.4.5 Siemens Healthcare Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hospital Acquired Infections (HAI) Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital Acquired Infections (HAI) Diagnostics Revenue
Table 3. Ranking of Global Top Hospital Acquired Infections (HAI) Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Molecular Diagnostics Tests
Table 6. Key Players of Other In-vitro Diagnostic Tests
Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hospital Acquired Infections (HAI) Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Hospital Acquired Infections (HAI) Diagnostics Players
Table 18. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2019)
Table 21. Global Hospital Acquired Infections (HAI) Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hospital Acquired Infections (HAI) Diagnostics Product Solution and Service
Table 24. Date of Enter into Hospital Acquired Infections (HAI) Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 34. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 36. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 40. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 46. China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 48. China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 52. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 64. India Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 66. India Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hospital Acquired Infections (HAI) Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hospital Acquired Infections (HAI) Diagnostics Market Share (2019-2020)
Table 70. Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2015-2020)
Table 74. BioMérieux Company Details
Table 75. BioMérieux Business Overview
Table 76. BioMérieux Product
Table 77. BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020) (Million US$)
Table 78. BioMérieux Recent Development
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Product
Table 82. Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020) (Million US$)
Table 83. Abbott Laboratories Recent Development
Table 84. Roche AG Company Details
Table 85. Roche AG Business Overview
Table 86. Roche AG Product
Table 87. Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020) (Million US$)
Table 88. Roche AG Recent Development
Table 89. Siemens Healthcare Company Details
Table 90. Siemens Healthcare Business Overview
Table 91. Siemens Healthcare Product
Table 92. Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020) (Million US$)
Table 93. Siemens Healthcare Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Molecular Diagnostics Tests Features
Figure 3. Other In-vitro Diagnostic Tests Features
Figure 4. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Bloodstream Infections (BSI) Case Studies
Figure 6. Urinary Tract Infections (UTI) Case Studies
Figure 7. Surgical Site Infections (SSI) Case Studies
Figure 8. Pneumonia Case Studies
Figure 9. Others Case Studies
Figure 10. Hospital Acquired Infections (HAI) Diagnostics Report Years Considered
Figure 11. Global Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players in 2019
Figure 16. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2019
Figure 18. North America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 病院治療グラム陰性菌感染症の世界市場（～2026年） Gram-negative bacteria are non-pathogenic in person with the normal immune system. However, in person with a weak immune system having gram negative bacteria can behave as significant pathogens. The ability to prevent the effect of such micro-organisms is significantly hampered by the resistance of …
- 院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…